120 related articles for article (PubMed ID: 34481023)
1. Co-delivery of bufalin and nintedanib via albumin sub-microspheres for synergistic cancer therapy.
Xu Y; Liu Y; Liu Q; Lu S; Chen X; Xu W; Shi F
J Control Release; 2021 Oct; 338():705-718. PubMed ID: 34481023
[TBL] [Abstract][Full Text] [Related]
2. Development, Optimization, and Pharmacokinetics Study of Bufalin/Nintedanib Co-loaded Modified Albumin Sub-microparticles Fabricated by Coaxial Electrostatic Spray Technology.
Chen P; Lu S; Pan B; Xu Y
AAPS PharmSciTech; 2021 Dec; 23(1):13. PubMed ID: 34888752
[TBL] [Abstract][Full Text] [Related]
3. Tumor-Targeted Delivery of Bufalin-Loaded Modified Albumin-Polymer Hybrid for Enhanced Antitumor Therapy and Attenuated Hemolysis Toxicity and Cardiotoxicity.
Xu Y; Tang L; Chen P; Chen M; Zheng M; Shi F; Wang Y
AAPS PharmSciTech; 2021 Apr; 22(4):137. PubMed ID: 33880681
[TBL] [Abstract][Full Text] [Related]
4. Synergistic anti-hepatoma effect of bufalin combined with sorafenib via mediating the tumor vascular microenvironment by targeting mTOR/VEGF signaling.
Wang H; Zhang C; Chi H; Meng Z
Int J Oncol; 2018 Jun; 52(6):2051-2060. PubMed ID: 29620259
[TBL] [Abstract][Full Text] [Related]
5. Biguanides decorated albumin nanoparticles loading nintedanib for synergic enhanced hepatocellular carcinoma therapy.
Xu Y; Liu Y; He T; Zhang Y; Wang M; Yuan H; Yang M
Colloids Surf B Biointerfaces; 2021 Nov; 207():112020. PubMed ID: 34403984
[TBL] [Abstract][Full Text] [Related]
6. Sequential Release of Paclitaxel and Imatinib from Core-Shell Microparticles Prepared by Coaxial Electrospray for Vaginal Therapy of Cervical Cancer.
Liu Z; Chen H; Lv F; Wang J; Zhao S; Li Y; Xue X; Liu Y; Wei G; Lu W
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445466
[TBL] [Abstract][Full Text] [Related]
7. Preparation and Study of Folate Modified Albumin Targeting Microspheres.
Zha Q; Zhang L; Guo Y; Bao R; Shi F; Shi Y
J Oncol; 2022; 2022():3968403. PubMed ID: 35126516
[TBL] [Abstract][Full Text] [Related]
8. Modulating the tumoral SPARC content to enhance albumin-based drug delivery for cancer therapy.
Zheng B; Chen Y; Niu L; Zhang X; Yang Y; Wang S; Chen W; Cai Z; Huang W; Huang W
J Control Release; 2024 Feb; 366():596-610. PubMed ID: 38184232
[TBL] [Abstract][Full Text] [Related]
9. mPEG-Cholic acid/TPGS mixed micelles for combined delivery of paclitaxel and bufalin to treat hepatocellular carcinoma.
Liu Y; Lu X; Zhang Z; Jiang S; Lv H
Pharm Dev Technol; 2022 Feb; 27(2):215-227. PubMed ID: 35105263
[TBL] [Abstract][Full Text] [Related]
10. Blood-Brain-Barrier-Penetrating Albumin Nanoparticles for Biomimetic Drug Delivery via Albumin-Binding Protein Pathways for Antiglioma Therapy.
Lin T; Zhao P; Jiang Y; Tang Y; Jin H; Pan Z; He H; Yang VC; Huang Y
ACS Nano; 2016 Nov; 10(11):9999-10012. PubMed ID: 27934069
[TBL] [Abstract][Full Text] [Related]
11. Bufalin-loaded bovine serum albumin nanoparticles demonstrated improved anti-tumor activity against hepatocellular carcinoma: preparation, characterization, pharmacokinetics and tissue distribution.
Zhang H; Huang N; Yang G; Lin Q; Su Y
Oncotarget; 2017 Sep; 8(38):63311-63323. PubMed ID: 28968991
[TBL] [Abstract][Full Text] [Related]
12. Albumin coated trimethyl chitosan-based targeting delivery platform for photothermal/chemo-synergistic cancer therapy.
Hu H; Qi Q; Dong Z; Yu X; Mo Y; Luo J; Wang Y; Du S; Lu Y
Carbohydr Polym; 2020 Aug; 241():116335. PubMed ID: 32507205
[TBL] [Abstract][Full Text] [Related]
13. Bufalin loaded biotinylated chitosan nanoparticles: an efficient drug delivery system for targeted chemotherapy against breast carcinoma.
Tian X; Yin H; Zhang S; Luo Y; Xu K; Ma P; Sui C; Meng F; Liu Y; Jiang Y; Fang J
Eur J Pharm Biopharm; 2014 Aug; 87(3):445-53. PubMed ID: 24846793
[TBL] [Abstract][Full Text] [Related]
14. Bufalin enhances antitumor effect of paclitaxel on cervical tumorigenesis via inhibiting the integrin α2/β5/FAK signaling pathway.
Liu F; Tong D; Li H; Liu M; Li J; Wang Z; Cheng X
Oncotarget; 2016 Feb; 7(8):8896-907. PubMed ID: 26758421
[TBL] [Abstract][Full Text] [Related]
15. Preparation of bufalin-loaded pluronic polyetherimide nanoparticles, cellular uptake, distribution, and effect on colorectal cancer.
Hu Q; Liang B; Sun Y; Guo XL; Bao YJ; Xie DH; Zhou M; Duan YR; Yin PH; Peng ZH
Int J Nanomedicine; 2014; 9():4035-41. PubMed ID: 25187707
[TBL] [Abstract][Full Text] [Related]
16. Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivo.
Wang W; Xi M; Duan X; Wang Y; Kong F
Int J Nanomedicine; 2015; 10():3737-50. PubMed ID: 26045664
[TBL] [Abstract][Full Text] [Related]
17. Co-delivery of paclitaxel and STAT3 siRNA by a multifunctional nanocomplex for targeted treatment of metastatic breast cancer.
Luo K; Gao Y; Yin S; Yao Y; Yu H; Wang G; Li J
Acta Biomater; 2021 Oct; 134():649-663. PubMed ID: 34289420
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel and etoposide-loaded Poly (lactic-co-glycolic acid) microspheres fabricated by coaxial electrospraying for dual drug delivery.
Zhang M; Tang Y; Zhu Z; Zhao H; Yao J; Sun D
J Biomater Sci Polym Ed; 2018 Nov; 29(16):1949-1963. PubMed ID: 29920151
[TBL] [Abstract][Full Text] [Related]
19. Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer.
Englinger B; Kallus S; Senkiv J; Heilos D; Gabler L; van Schoonhoven S; Terenzi A; Moser P; Pirker C; Timelthaler G; Jäger W; Kowol CR; Heffeter P; Grusch M; Berger W
J Exp Clin Cancer Res; 2017 Sep; 36(1):122. PubMed ID: 28882160
[TBL] [Abstract][Full Text] [Related]
20. Ratiometric co-encapsulation and co-delivery of doxorubicin and paclitaxel by tumor-targeted lipodisks for combination therapy of breast cancer.
Feng C; Zhang H; Chen J; Wang S; Xin Y; Qu Y; Zhang Q; Ji W; Yamashita F; Rui M; Xu X
Int J Pharm; 2019 Apr; 560():191-204. PubMed ID: 30769131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
